HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 23, No 09, September 2019 – Healthy Ageing — How Science is chipping in       » Officials in China make progress in development of new drugs       » The Science of Healthy Ageing       » Thailand Medtech landscape - Customer to Innovator       » China-Thailand Joint Research Institute on Medicine Launched in Bangkok      
INSIDE INDUSTRY
Molecular test to predict immunotherapy response for kidney cancer
Study was conducted using the CLEARScore test that identifies eight genes linked to immunotherapy

Immunotherapy drugs such as PD-L1 checkpoint inhibitors represent the front-line treatment for kidney cancer. But it is expensive, benefits only a subset of patients and is futile in the majority of patients.

Researchers from the National Cancer Centre Singapore and Lucence Diagnostics have conducted a study using Lucence鈥檚 molecular test, CLEARScore, to predict whether a kidney cancer patient will or will not benefit from immunotherapy thus helping to reduce futile costs and side effects.

CLEARScore is an algorithm involving eight genes in the tumour, which classifies kidney cancer by molecular type.

Kidney cancer is among the ten most common cancers in men and women across the world. In 2018, there were over 400,000 new cases of kidney cancer globally.

Previously, the test has been used to successfully predict treatment response of kidney cancer patients to tyrosine kinase inhibitors, a type of targeted therapy. The results were published in 2015 in European Urology.

Click here for the complete issue.

NEWS CRUNCH  
news Philip Morris International opens artificial intelligence competition to develop improved strategies for medical diagnosis
news Kaspersky partners with Temasek Polytechnic to offer technical cybersecurity courses to more Singaporeans
news Discover the Asian nutraceuticals market at Vitafoods Asia 2019
news Singapore FinTech Festival and SWITCH come together - to bring the global innovation community to Singapore
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
SPOTLIGHT  
LIFE OF A SCIENTIST  

APBN Editorial Calendar 2019
January:
Taiwan Medical tourism
February:
Marijuana as medicine — Legal marijuana will open up scientific research
March:
Driven by curiosity
April:
Career developments for researchers
May:
What's cracking — Antibodies in ostrich eggs
June:
Clinical trials — What's in a name?
July:
Traditional Chinese medicine in modern healthcare — Integrating both worlds
August:
Digitalization vs Digitization — Exploring Emerging Trends in Healthcare
September:
Healthy Ageing — How Science is chipping in
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy